Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2021-12-23 Governance Information
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the rules, qualifications, nomination, rights, and duties of independent directors in the company. It references relevant laws and regulatory frameworks, including the Beijing Stock Exchange rules, and outlines governance practices related to independent directors. There is no financial data, no audit or financial report, no announcement of voting results, no earnings data, no capital or financing update, no legal proceedings, no merger or acquisition information, and no shareholder transactions. The document is a governance-related policy document describing internal rules and governance practices of the company. Therefore, it fits best under Governance Information (CGR). The document length is over 6,000 characters and contains detailed governance content, not a brief announcement or certification, so it is not RNS or RPA. Hence, the classification is CGR with high confidence.
2021-12-23 Chinese
募集资金专项管理制度
Governance Information Classification · 95% confidence The document is titled '募集资金专项管理制度' which translates to 'Special Management System for Raised Funds'. It details the company's internal policies and procedures regarding the management, storage, and use of funds raised through securities issuance. It includes sections on board approvals, fund usage restrictions, supervision, and reporting requirements. There is no indication that this is a financial report, audit, or announcement of voting results. It is a governance-related document outlining internal rules and compliance measures related to capital management. The document length is under 5,000 characters and is a detailed policy document rather than a brief announcement or certification. Therefore, the most appropriate classification is Governance Information (CGR).
2021-12-23 Chinese
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules'. It details the qualifications, duties, appointment, and removal procedures of the company's board secretary. It references company laws, securities exchange rules, and internal governance. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, or other report types. The document is a governance-related internal regulation document approved by the board. It is not a report or announcement of financial results or shareholder votes. Therefore, it fits best under Governance Information (CGR). The document length is 2465 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2021-12-23 Chinese
关于修订公司章程的公告
Governance Information Classification · 95% confidence The document is an announcement regarding proposed amendments to the company's Articles of Association (公司章程). It details specific changes to governance rules, shareholder meeting procedures, board powers, and other corporate governance matters. The document references compliance with company law and stock exchange rules, and it is issued by the company's board. There is no financial data, audit information, or report attached. The content focuses on governance structure and rules, which aligns with Governance Information filings. The document is not a full report but a detailed announcement of governance changes, fitting the Governance Information (CGR) category.
2021-12-23 Chinese
关于终止磷酸奥司他韦干混悬剂研发的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the termination of a specific drug development project. It discusses the decision to stop the research and development of a pharmaceutical product due to regulatory changes and strategic considerations. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is a regulatory announcement about business operations and R&D activities, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-23 Chinese
内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人登记管理制度' which translates to 'Insider Information Insider Registration Management System'. It details the company's internal policy and procedures for managing insider information, including definitions, responsibilities, confidentiality, and legal compliance. It references company board meetings and regulatory compliance but does not contain financial statements, earnings data, or shareholder voting results. It is a governance-related document outlining internal rules and management practices regarding insider information. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and it is not a brief announcement or certification, so it is not RPA or RNS. Hence, the classification is CGR with high confidence.
2021-12-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.